A non-dairy probiotic's (poi) influence on changing the gastrointestinal tract's microflora environment

Alternative Therapies in Health and Medicine

Volumn 11, Issue 1, 2005, Pages 58-64

  Brown, Amy C ^a   Shovic, Anne ^a   Ibrahim, Salam A ^b   Holck, Peter ^c   Huang, Alvin ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POI; PROBIOTIC AGENT; UNCLASSIFIED DRUG; YOGHURT;

ADULT; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIACEAE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENTEROBACTER; ESCHERICHIA COLI; FECES CULTURE; FEMALE; GASTROINTESTINAL TRACT; HUMAN; KLEBSIELLA; LACTOBACILLUS; LACTOCOCCUS; MALE; MICROFLORA; NORMAL HUMAN;

ADULT; COLOCASIA; COLONY COUNT, MICROBIAL; CROSS-OVER STUDIES; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INTESTINES; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT ROOTS; PROBIOTICS; REFERENCE VALUES; TIME FACTORS;

EID: 12144266973     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fuller R. Probiotics in human medicine. Gut. 1991;32(4): 439-42.
2. Gismondo MR, Drago L, Lombardi A. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents 1999;12(4): 287-292.
3. Salminen SE, Isolauri T, Onnela T. Gut microflora in health and disease. Chemotherapy. 1995;41: 5-51.
4. Bengmark S. Colonic food: pre- and probiotics. Am J Gastroenterol. 2000;95(1 Suppl):S5-7. Review.
5. de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000;71(2): 405-411.
6. Bradbury JH, Holloway WD, Bradshaw K, Jealous W, Phimpisane T. Effect of cooking on nutrient content of tropical root crops from the South Pacific. J Sci Food Agric. 1988;43: 333-342.
7. Huang AS, Titchenal CA, Meilleur BA. Nutrient composition of taro corms and bread-fruit. J Food Compos Anal. 2000;13: 859-864.
8. Miller C, Bauer A, Denning H. Taro as a source of thiamine, riboflavin, and niacin. J Am Diet Assoc. 1952;28(5): 435-438.
9. Glaser J, Lawrence RA, Harrison A, Ball RM. Poi - ts use as a food for normal, allergic and potentially allergic children. Ann Allergy. 1967;25: 496-500.
10. Huang AS, Lam SY, Nakayama TM, Lin H. Microbiological and chemical changes in poi stored at 20°C. J Agric Food Chem. 1994;42(1): 45-48.
11. Allen ON, Allen EK. The manufacture of poi from taro in Hawaii: with special emphasis upon its fermentation. Hawaii Agricultural Experiment Station 1933;70: 1-30.
12. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillu casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr. 1998;52: 899-907.
13. Benno Y, Mitsuoka T. Impact of Bifidobacterium longum on human fecal microflora. Microbiol Immunol. 1992;36: 683-694.
14. Ling WH, Korpela R, Mykkanen H, Salminen S, Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr. 1994;124: 18-23.
15. Pahwa A, Mathur BN. Assessment of a bifidus containing infant formula. Part II. Implantation of Bifidobacterium bifidum. Indian J Dairy Sci. 1987;40: 364-367.
16. Langhendries JP, Detry J, Van Hees J, et al. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr. 1995;21: 177-181.
17. Brown AC, Valiere A. The medicinal uses of poi. Nutr Clin Care. 2204;7(2): 69-74.
18. Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr Clin Care. 2004;7(2): 56-68.
19. Ibrahim SA, Salameh MM. Simple and rapid method for screening antimicrobial activities of Bifidobacterium species of human isolates. J Rapid Methods and Automation Microbiol. 2001;9(1): 52-63.
20. Ibrahim SA, Bezkorovainy A. Survival of bifidobacteria in the presence of bile salts. J Sci Food Agric. 1993;62: 351-354.
21. Lidbeck A, Gustafsson JA, Nord CE. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora. Scand J Infect Dis. 1987;19(5):531-537.
22. Goossens D, Jonkers D, Russel M, et al. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther. 2003;18(5): 495-505.
23. Bouhnik Y, Pochart P, Marteau P, et al. Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastrointerology. 1992;102(3): 875-878.
24. Goldin BR, Gorbach SL, Saxelin M, et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci. 1992;37(1): 121-128.
25. Bougie D, Roland N, Lebeurrier F, Arhan P. Effect of proprionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects. Scand J Gastroenterol. 1999;34(2): 144-148.
26. Adolfsson O, Meydani SN, Russell RM. Yogurt and gut function. Am J Clin Nutr. 2004;80(2): 245-256.
27. Solis B, Nova E, Gomez S, et al. The effect of fermented milk on interferon production in malnourished children and in anorexia nervosa patients undergoing nutritional care. Eur J Clin Nutr. 2002;4: S27-S33.
28. Brown AC, Liu J, Jadus MR, Reitzenstein JE. The antiproliferative effect of diluted poi (Colocasia esculenta) on colonic adenocarcinoma cells in vitro. (In press.)
29. Apostolou E, Pelto L, Kirjavainen PV, Isolauri E, Salminen SJ, Gibson GR. Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridization. FEMS Immunol Med Microbiol. 2001;30(3): 217-221.
30. Amann MM, Kullen MJ, Martini MC, Busta FF, Brady LJ. Consumption of exogenous bifidobacteria does not alter fecal bifidobacteria and breath hydrogen excretion in humans. J Nutr. 1998;128(6): 996-1002.
31. Bayless TM, Paige DM, Ferry GD. Lactose intolerance and milk drinking habits. Gastroenterology. 1971;60(4): 605-608.
32. Kretchmer N. Lactose and lactase. Sci Am. 1972;227(4): 71-78.
33. Pochart P, Marteau P, Bouhnik Y, et al. Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr. 1992;55: 78-80.
34. Marteau P, Minekus M, Havenaar R, Huis int't Veld JHJ. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci. 1997;80: 1031-1037.
35. Bouhnik Y, Flourie B, D'Agay-Abensour L, et al. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr. 1997;127(3): 444-448.
36. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. J Am Med Assoc. 1996;275(11): 870-876.